Department of Microbiology and Immunology, University of Melbourne, Parkville 3010, Victoria, Australia.
J Immunol. 2011 Aug 15;187(4):1895-902. doi: 10.4049/jimmunol.1100664. Epub 2011 Jul 15.
The human HLA-A2-restricted CD8(+) T cell response to influenza A virus (IAV) is largely directed against the matrix protein-derived M1(58-66) epitope and represents an archetypal example of CD8(+) T cell immunodominance. In this study, we examined the CD8(+) T cell hierarchy to M1(58-66) and two subdominant IAV-specific epitopes: NS1(122-130) and PA(46-55) in HLA-A2(+) human subjects and HLA-A2.1 transgenic (HHD) mice. Using epitope-based lipopeptides, we show that the CD8(+) T cell hierarchy induced by IAV infection could also be induced by lipopeptide vaccination in a context outside of viral infection when the Ag load is equalized. In the HHD HLA-A2.1 mouse model, we show that the naive T cell precursor frequencies, and competition at the Ag presentation level, can predict the IAV-specific CD8(+) T cell hierarchy. Immunization of mice with subdominant epitopes alone was unable to overcome the dominance of the M1(58-66)-specific response in the face of IAV challenge; however, a multiepitope vaccination strategy was most effective at generating a broad and multispecific response to infection.
人类 HLA-A2 限制性 CD8(+) T 细胞对甲型流感病毒 (IAV) 的反应主要针对基质蛋白衍生的 M1(58-66) 表位,这是 CD8(+) T 细胞免疫优势的典型例子。在这项研究中,我们研究了 M1(58-66)和两个亚显性 IAV 特异性表位(NS1(122-130)和 PA(46-55))在 HLA-A2(+)人类受试者和 HLA-A2.1 转基因(HHD)小鼠中的 CD8(+) T 细胞优势等级。使用基于表位的脂肽,我们表明,当抗原负荷相等时,IAV 感染诱导的 CD8(+) T 细胞优势等级也可以通过脂肽疫苗接种在病毒感染之外的情况下诱导。在 HHD HLA-A2.1 小鼠模型中,我们表明,在面对 IAV 挑战时,幼稚 T 细胞前体频率和抗原呈递水平的竞争可以预测 IAV 特异性 CD8(+) T 细胞优势等级。单独用亚显性表位免疫小鼠无法克服 M1(58-66)-特异性反应的优势;然而,多表位疫苗接种策略在感染时最有效地产生广泛和多特异性的反应。